MAOIS
发表于 2025-3-26 22:46:13
Ekaterina Kulchavenya MDh traceability and an update to the chapter on tools to present DOORS Next Generation. ..Requirements Engineering. is written by practitioners for practitioners and students who want to develop their knowledge of the subject area. .978-3-319-86997-1978-3-319-61073-3
Electrolysis
发表于 2025-3-27 02:49:37
Ekaterina Kulchavenya MDund dessen Ergebnisse nutzt. Durch bewussten Einsatz dieser Methoden kann das Projektmanagement verbessert werden. Eine Darstellung der Rahmenbedingungen für den optimalen Einsatz von Requirements Engineering rundet das Buch ab. .978-3-642-29432-7Series ISSN 1439-5428 Series E-ISSN 2522-0667
Institution
发表于 2025-3-27 06:47:34
Ekaterina Kulchavenya MDnts engineering for system development. As before, a web site supporting additional material is available at: http://www.requirementsengineering.info Elizabeth Hull Ken Jackson Jeremy Dick June 2004 vii Preface978-1-84628-075-7
DEVIL
发表于 2025-3-27 10:02:20
Ekaterina Kulchavenya MDthe highly regulated and sensible healthcare domain are and how they can be overcome..This book brings together the knowledge of 22 researchers, engineers, lawyers, and CEOs that have experience in the developm978-3-319-37953-1978-3-319-09798-5
奇怪
发表于 2025-3-27 16:21:43
Clinical Features of Urogenital Tuberculosis,etc.) and properties of Mtb (persistence and resistance). Clinical features of UGTB and properties of MBT may be different in different regions. UGTB hide under the guises of other diseases, mostly – cystitis and prostatitis. None UGTB patient was diagnosed on the first visit, because this disease h
pericardium
发表于 2025-3-27 20:46:06
Male Genital Tuberculosis,cturition syndrome (8 %), urethral discharge (4 %), and scrotal fistula (4 %). One-third of the patients had pulmonary tuberculosis. Four patients (16 %) had underlying human immunodeficiency virus infection. Tuberculous epididymo-orchitis should be considered in the patients who present with a scro
Tinea-Capitis
发表于 2025-3-28 00:35:39
Therapy of Urogenital Tuberculosis,nce to both isoniazid and rifampicin), is based only on observational studies and expert opinion (WHO 2012)..The cornerstone of antituberculous therapy is multidrug treatment to decrease the duration of therapy and to diminish the likelihood that drug-resistant organisms will develop.
装饰
发表于 2025-3-28 03:05:48
http://reply.papertrans.cn/95/9443/944280/944280_38.png
滔滔不绝地讲
发表于 2025-3-28 07:41:50
Urogenital Tuberculosis: Epidemiology, Diagnosis, Therapy978-3-319-04837-6
vertebrate
发表于 2025-3-28 13:22:42
http://reply.papertrans.cn/95/9443/944280/944280_40.png